Back

Short term benzbromarone treatment in patients with chronic kidney disease accompanied with hyperuricemia undergoing elective coronary intervention a prospective study

28 August 2017 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 5 - PCI - Adjunctive drug therapy PCI: procedural complications ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Ji Fang He

Beijing Chaoyang Hospital affiliated to Capital Medical University, Beijing (China)

13 More presentations in this session

Presentation thumbnail
Associate Professor B. Zheng (Beijing, CN)
Abstract Slides
Presentation thumbnail
Doctor S. Cornara (Savona, IT)
Abstract Slides
Presentation thumbnail
Doctor C. Cheung (Hong Kong, HK)
Abstract Slides
Presentation thumbnail
Professor Y. Lopatin (Volgograd, RU)
Abstract
Presentation thumbnail
Doctor C. Chen (Taipei, TW)
Abstract Slides

Access the full session

Session thumbnail
Poster session 5 - PCI - Adjunctive drug therapy

The Event

Event poster

ESC Congress 2017

28 August 2017 14:00 CET
You may be interested in
thumbnail
Congress Presentation
The correlation of elevated uric acid to cardiovascular outcomes of admitted acute coronary syndrome patients from 2018 to 2022: a single-center, cross-sectional retrospective study
29 August 2025
thumbnail
Congress Presentation
The clinical outcome of fractional flow reserve based coronary revascularization strategy of the patients on hemodialysis
27 August 2021
thumbnail
Congress Presentation
Role of urate and xanthine oxidase in chronic heart failure with chronic kidney disease
29 June 2021
thumbnail
Webinar
Percutaneous interventions in patients with coronary artery disease and specific clinical conditions - IC Core Curriculum 6
9 November 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources